Hyperglycemic subjects (n = 50) | |||||
---|---|---|---|---|---|
TEST (10:1) | TEST (15:1) | TEST (20:1) | Control | ||
insulina | 0 min | 10.0 ± 0.77 | 10.4 ± 1.13 | 10.9 ± 1.39 | 9.5 ± 0.57 |
uIU/mL | 15 min | 15.2 ± 1.41 | 16.4 ± 1.57 | 17.5 ± 1.95 | 21.6 ± 1.75 |
30 min | 24.5 ± 2.31 | 24.6 ± 2.72 | 25.2 ± 2.48 | 33.3 ± 3.19 | |
60 min | 30.8 ± 2.80 | 29.5 ± 3.41 | 33.7 ± 3.74 | 35.7 ± 4.46 | |
120 min | 19.7 ± 3.59 | 20.2 ± 3.48 | 21.7 ± 4.36 | 16.1 ± 2.74 | |
insulin AUCa (uIU/mLxhr) | 47.2 ± 4.69 | 46.9 ± 5.34 | 51.8 ± 6.24 | 53.9 ± 5.58 | |
C-peptidea | 0 min | 2.43 ± 0.13 | 2.40 ± 0.14 | 2.53 ± 0.16 | 2.42 ± 0.12 |
(ng/mLxhr | 15 min | 3.12 ± 0.14 | 3.21 ± 0.14 | 3.39 ± 0.17 | 3.72 ± 0.19 |
30 min | 4.30 ± 0.22 | 4.31 ± 0.23 | 4.52 ± 0.20 | 5.15 ± 0.27 | |
60 min | 5.87 ± 0.27 | 5.89 ± 0.30 | 6.37 ± 0.29 | 6.51 ± 0.39 | |
120 min | 5.32 ± 0.31 | 5.48 ± 0.31 | 5.66 ± 0.32 | 4.78 ± 0.31 | |
C-peptide AUCa (ng/mLxhr) | 9.76 ± 0.44 | 9.87 ± 0.46 | 10.46 ± 0.46 | 10.44 ± 0.53 |